Podcasts about chicago medicine

September 2, 2025 City Club event description: Join the Cancer Center Directors of the member hospitals of the Chicago Breast Cancer Research Consortium—a groundbreaking collaboration between University of Chicago Medicine, Lurie Cancer Center at Northwestern Medicine, and Rush MD Anderson Cancer Center—for a powerful conversation on how Chicago is redefining breast cancer research. Convened and […]

Multiple system atrophy is a rare, sporadic, adult-onset, progressive, and fatal neurodegenerative disease. Accurate and early diagnosis remains challenging because it presents with a variable combination of symptoms across the autonomic, extrapyramidal, cerebellar, and pyramidal systems. Advances in brain imaging, molecular biomarker research, and efforts to develop disease-modifying agents have shown promise to improve diagnosis and treatment. In this episode, Casey Albin, MD speaks with Tao Xie, MD, PhD, author of the article “Multiple System Atrophy” in the Continuum® August 2025 Movement Disorders issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Xie is director of the Movement Disorder Program, chief of the Neurodegenerative Disease Section in the department of neurology at the University of Chicago Medicine in Chicago, Illinois. Additional Resources Read the article: Multiple System Atrophy Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr. Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello everyone, this is Dr Casey Albin. Today I'm interviewing Dr Tao Xie about his article on diagnosis and management of multiple system atrophy, which appears in the August 2025 Continuum issue on movement disorders. Welcome to the podcast, and please introduce yourself to our audience. Dr Xie: Thank you so much, Dr Albin. My name is Tao Xie, and sometimes people also call me Tao Z. I'm a mood disorder neurologist, professor of neurology at the University of Chicago. I'm also in charge of the mood disorder program here, and I'm the section chief in the neurodegenerative disease in the Department of Neurology at the University of Chicago Medicine. Thank you for having me, Dr Albin and Dr Okun and the American Academy of Neurology. This is a great honor and pleasure to be involved in this education session. Dr Albin: We are delighted to have you, and thank you so much for the thoughtful approach to the diagnosis and management. I really want to encourage our listeners to check out this article. You know, one of the things that you emphasize is multiple system atrophy is a fairly rare condition. And I suspect that clinicians and trainees who even have a fair amount of exposure to movement disorders may not have encountered that many cases. And so, I was hoping that you could just start us off and walk us through what defines multiple system atrophy, and then maybe a little bit about how it's different from some of the more commonly encountered movement disorders. Dr Xie: This is a really good question, Dr Albin. Indeed, MSA---multisystem atrophy----is a rare disease. It is sporadic, adult-onset, progressive, fatal neurodegenerative disease. By the name MSA, multisystem atrophy. Clinically, it will present with multiple symptoms and signs involving multiple systems, including symptoms of autonomic dysfunction and symptoms of parkinsonism, which is polyresponsive to the levodopa treatment; and the symptom of cerebellar ataxia, and symptom of spasticity and other motor and nonmotor symptoms. And you may be wondering, what is the cause- underlying cause of these symptoms? Anatomically, we can find the area in the basal ganglia striatonigral system, particularly in the putamen and also in the cerebellar pontine inferior, all of the nuclear area and the specific area involved in the autonomic system in the brain stem and spinal cord: all become smaller. We call it atrophy. Because of the atrophy in this area, they are responsible for the symptom of parkinsonism if it is involved in the putamen and the cerebral ataxia, if it's involved in the pons and cerebral peduncle and the cerebellum. And all other area, if it's involved in the autonomic system can cause autonomic symptoms as well. So that's why we call it multisystem atrophy. And then what's the underlying cellular and subcellular pathological, a hallmark that is in fact caused by misfolded alpha-synuclein aggregate in the oligodontia site known as GCI---glial cytoplasmic increasing bodies---in the cells, and sometimes it can also be found in the neuronal cell as well in those areas, as mentioned, which causes the symptom. But clinically, the patient may not present all the symptoms at the same time. So, based on the predominant clinical symptom, if it's mainly levodopa, polyresponsive parkinsonism, then we call it MSAP. If it's mainly cerebellar ataxia, then we call it MSAC. But whether we call it MSP or MSC, they all got to have autonomic dysfunction. And also as the disease progresses, they can also present both phenotypes together. We call that mixed cerebellar ataxia and parkinsonism in the advanced stage of the disease. So, it is really a complicated disease. The complexity and the similarity to other mood disorders, including parkinsonism and the cerebellar ataxia, make it really difficult sometimes, particularly at the early stages of disease, to differentiate one from the other. So, that was challenging not only for other professionals, general neurologists and even for some movement disorder specialists, that could be difficult particularly if you aim to make an accurate and early diagnosis. Dr Albin: Absolutely. That is such a wealth of knowledge here. And I'm going to distill it just a little bit just to make sure that I understand this right. There is alpha-synuclein depositions, and it's really more widespread than one would see maybe in just Parkinson's disease. And with this, you are having patients present with maybe one of two subtypes of their clinical manifestations, either with a Parkinson's-predominant movement disorder pattern or a cerebellar ataxia type movement disorder pattern. Or maybe even mixed, which really, you know, we have to make things quite complicated, but they are all unified and having this shared importance of autonomic features to the diagnosis. Have I got that all sort of correct? Dr Xie: Correct. You really summarize well. Dr Albin: Fantastic. I mean, this is quite a complicated disease. I would pose to you sort of a case, and I imagine this is quite common to what you see in your clinic. And let's say, you know, a seventy-year-old woman comes to your clinic because she has had rigidity and poor balance. And she's had several falls already, almost always from ground level. And her family tells you she's quite woozy whenever she gets up from the chair and she tends to kind of fall over. But they noticed that she's been stiff,and they've actually brought her to their primary care doctor and he thought that she had Parkinson's disease. So, she started levodopa, but they're coming to you because they think that she probably needs a higher dose. It's just not working out very well for her. So how would you sort of take that history and sort of comb through some of the features that might make you more concerned that the patient actually has undiagnosed multiple systems atrophy? Dr Xie: This is a great case, because we oftentimes can encounter similar cases like this in the clinic. First of all, based on the history you described, it sounds like an atypical parkinsonism based on the slowness, rigidity, stiffness; and particularly the early onset of falls, which is very unusual for typical Parkinson disease. It occurs too early. If its loss of balance, postural instability, and fall occurred within three years of disease onset---usually the motor symptom onset---then it raises a red flag to suspect this must be some atypical Parkinson disorders, including multiple system atrophy. Particularly, pou also mentioned that the patient is poorly responsive to their levodopa therapy, which is very unusual because for Parkinson disease, idiopathic Parkinson disease, we typically expect patients would have a great response to the levodopa, particularly in the first 5 to 7 years. So to put it all together, this could be atypical parkinsonism, and I could not rule out the possibility of MSA. Then I need to check more about other symptoms including autonomic dysfunction, such as orthostatic hypertension, which is a blood pressure drop when the patient stands up from a lying-down position, or other autonomic dysfunctions such as urinary incontinence or severe urinary retention. So, in the meantime, I also have to put the other atypical Parkinson disorder on the differential diagnosis, such as PSP---progressive supranuclear palsy---and the DLBD---dementia with Lewy body disease.---Bear this in mind. So, I want to get more history and more thorough bedside assessment to rule in or rule out my diagnosis and differential diagnosis. Dr Albin: That's super helpful. So, looking for early falls, the prominence of autonomic dysfunction, and then that poor levodopa responsiveness while continuing to sort of keep a very broad differential diagnosis? Dr Xie: Correct. Dr Albin: One of the things that I just have to ask, because I so taken by this, is that you say in the article that some of these patients actually have preservation of smell. In medical school, we always learn that our Parkinson's disease patients kind of had that early loss of smell. Do you find that to be clinically relevant? Is that- does that anecdotally help? Dr Xie: This is a very interesting point because we know that the loss of smelling function is a risk effect, a prodromal effect, for the future development of Parkinson disease. But it is not the case for MSA. Strange enough, based on the literature and the studies, it is not common for the patient with MSA to present with anosmia. Some of the patients may have mild to moderate hyposmia, but not to the degree of anosmia. So, this is why even in the more recent diagnosis criteria, the MDS criteria published 2022, it even put the presence of anosmia in the exclusion criteria. So, highlight the importance of the smell function, which is well-preserved for the majority in MSA, into that category. So, this is a really interesting point and very important for us, particularly clinicians, to know the difference in the hyposmia, anosmia between the- we call it the PD, and the dementia Lewy bodies versus MSA. Dr Albin: Fascinating. And just such a cool little tidbit to take with us. So, the family, you know, you're talking to them and they say, oh yes, she has had several fainting episodes and we keep taking her to the primary care doctor because she's had urinary incontinence, and they thought maybe she had urinary tract infections. We've been dealing with that. And you're sort of thinking, hm, this is all kind of coming together, but I imagine it is still quite difficult to make this diagnosis based on history and physical alone. Walk our listeners through sort of how you're using MRI and DAT scan and maybe even some other biomarkers to help sort of solidify that diagnosis. Dr Xie: Yeah, that's a wonderful question. Yeah. First of all, UTI is very common for patients with MSA because of urinary retention, which puts them into a high risk of developing frequent UTI. That, for some patients, could be the very initial presentation of symptoms. In this case, if we check, we say UTI is not present or UTI is present but we treat it, then we check the blood pressure and we do find also hypertension---according to new diagnosis criteria, starting drop is 20mm mercury, but that's- the blood pressure drop is ten within three minutes. And also, in the meantime the patients present persistent urinary incontinence even after UTI was treated. And then the suspicion for MS is really high right at this point. But if you want increased certainty and a comfortable level on your diagnosis, then we also need to look at the brain MRI mark. This is a required according to the most recent MDS diagnosis criteria. The presence of the MRI marker typical for MSA is needed for the diagnosis of clinically established MSA, which holds the highest specificity in the clinical diagnosis. So then, we have- we're back to your question. We do need to look at the brain MRI to see whether evidence suggestive of atrophy around the putamen area, around the cerebellar pontine inferior olive area, is present or not. Dr Albin: Absolutely. That's super helpful. And I think clinicians will really take that to sort of helping to build a case and maybe recognizing some of this atypical Parkinson's disease as a different disease entity. Are there any other biomarkers in the pipeline that you're excited about that may give us even more clarity on this diagnosis? Dr Xie: Oh, yeah. This is a very exciting area. In terms of biomarker for the brain imaging, particularly brain MRI, in fact, today there's a landmark paper just published in the Java Neurology using AI, artificial intelligence or machine learning aid, diagnoses a patient with parkinsonism including Parkinson's disease, MSA, and PSP, with very high diagnostic accuracy ranging from 96% to 98%. And some of the cases even were standard for autopsy, with pathological verification at a very high accurate rate of 93.9%. This is quite amazing and can really open new diagnosis tools for us to diagnose this difficult disease; not only in an area with a bunch of mood disorder experts, but also in the rural area, in the area really in need of mood disorder experts. They can provide tremendous help to provide accurate, early diagnosis. Dr Albin: That's fantastic and I love that, increasing the access to this accurate diagnosis. What can't artificial intelligence do for us? That's just incredible. Dr Xie: And also, you know, this is just one example of how the brain biomarker can help us. Theres other---a fluid biomarker, molecular diagnostic tools, is also available. Just to give you an example, one thing we know over the past couple years is skin biopsy. Through the immunofluorescent reaction, we can detect whether the hallmark of abnormally folded, misfolded, and the phosphorate, the alpha-synuclein aggregate can be found just by this little pinch of skin biopsy. Even more advanced, there's another diagnosis tool we call the SAA, we call the seizure amplification assay, that can even help us to differentiate MSA from other alpha-synucleinopathy, including Parkinson disease and dementia with Lewy bodies. If we get a little sample from CSF, spinal cerebral fluids, even though this is probably still at the early stage, a lot of developments still ongoing, but this, this really shows you how exciting this area is now. We're really in a fast forward-moving path now. Dr Albin: It's really incredible. So, lots coming down the track in, sort of, MRI, but also with CSF diagnosis and skin biopsies. Really hoping that we can hone in some of those tools as they become more and more validated to make this diagnosis. Is that right? Dr Xie: Correct. Dr Albin: Amazing. We can talk all day about how you manage these in the clinic, and I really am going to direct our listeners to go and read your fantastic article, because you do such an elegant job talking about how this takes place in a multidisciplinary setting, if at all possible. But as a neurointensivist, I was telling you, we have so much trouble in the hospital. We have A-lines, and we have the ability to get rapid KUBs to look at Ilias, and we can have many people as lots of diagnosis, and we still have a lot of trouble treating autonomiclike symptoms. Really, really difficult. And so, I just wanted to kind of pick your brain, and I'll start with just the one of orthostatic hypotension. What are some of the tips that you have for, you know, clinicians that are dealing with this? Because I imagine that this is quite difficult to do without patients. Dr Xie: Exactly. This is indeed a very difficult symptom to deal with, particularly at an outpatient setting. But nowadays with the availability of more medication---to give an example, to treat patients with orthostatic hypertension, we have not only midodrine for the cortisol, we also have droxidopa and several others as well. And so, we have more tools at hand to treat the patient with orthostatic hypertension. But I think the key thing here, particularly for us to the patient at the outpatient setting: we need to educate the patient's family well about the natural history of the disease course. And we also need to tell them what's the indication and the potential side effect profile of any medication we prescribe to them so that they can understand what to expect and what to watch for. And in the meantime, we also need to keep really effective and timely communication channels, make sure that the treating physician and our team can be reached at any time when the patient and family need us so that we can be closely monitoring, their response, and also monitoring potential side effects as well to keep up the quality of care in that way. Dr Albin: Yeah, I imagine that that open communication plays a huge role in just making sure that patients are adapting to their symptoms, understanding that they can reach out if they have refractory symptoms, and that- I imagine this takes a lot of fine tuning over time. Dr Xie: Correct. Dr Albin: Well, this has just been such a delight to get to talk to you. I really feel like we could dive even deeper, but I know for the sake of time we have to kind of close out. Are there any final points that you wanted to share with our listeners before we end the interview? Dr Xie: I think for the patients, I want them to know that nowadays with advances in science and technology, particularly given a sample of rapid development in the diagnostic tools and the multidisciplinary and multisystemic approach to treatment, nowadays we can make an early and accurate diagnosis of the MSA, and also, we can provide better treatment. Even though so far it is still symptomatically, mainly, but in the near future we hope we can also discover disease-modifying treatment which can slow down, even pause or prevent the disease from happening. And for the treating physician and care team professionals, I just want them to know that you can make a difference and greatly help the patient and the family through your dedicated care and also through your active learning and innovative research. You can make a difference. Dr Albin: That's amazing and lots of hope for these patients. Right now, you can provide really great care to take care of them, make an early and accurate diagnosis; but on the horizon, there are really several things that are going to move the field forward, which is just so exciting. Again today, I've been really greatly honored and privileged to be able to talk to Dr Tao Xie about his article on diagnosis and management of multiple system atrophy, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes for this and other issues. And thank you again to our listeners for joining us today. Dr Xie: Thank you so much for having me. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Featuring: David T. Rubin, MD, University of Chicago Medicine The GI Research Foundation was able to produce this podcast with sponsorships from Metro Infusion Center. David T. Rubin, MD, Joseph B. Kirsner Professor of Medicine and Chief of Gastroenterology, Hepatology and Nutrition at the University of Chicago Medicine, explores challenges 1–5 of the top ten faced by people with Crohn's disease and ulcerative colitis. He shares how health care providers and researchers are working to overcome these obstacles and improve patients' lives. To access other episodes of Visceral: Listen to Your Gut and learn more about the GI Research Foundation's support of clinical and laboratory research to treat, prevent, and cure digestive diseases, please visit https://www.giresearchfoundation.org/. Available on Apple Podcasts, Spotify, and everywhere else you listen.

Dr. Ben Derman of the University of Chicago Medicine joins the show to unpack major updates in multiple myeloma presented at ASCO and EHA 2025. He discusses the growing role of quadruple therapy across all patient populations and its implications for the future of autologous stem cell transplant, including insights from the MIDAS trial on MRD-guided transplant decisions. Additional highlights include MRD-negativity as a potential off-ramp for maintenance therapy, evolving data from frontline triplet vs. quadruplet studies, real-world referral trends, CARTITUDE-4 subgroup outcomes, and the expanding utility of bispecifics and trispecific antibodies, particularly for extramedullary disease. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Bonnie Tinder is the founder and CEO of Raven Intelligence, an independent B2B peer review site that amplifies the voice of the customer. She focuses on software customers, consulting partners, and software vendors and helps identify the best partners for their needs. In this episode, Bonnie shares insights from a recent Salesforce event, exploring how AI agents, data clouds, and robotics are reshaping customer experience, software implementation, and enterprise transformation.Episode 52 | AI Agents in ActionThe Big Themes:Campaigns Are Out, Conversations Are In: Marketing is undergoing a radical transformation. Gone are the days of mass email blasts and no-reply addresses. Instead, AI is ushering in a new era of real-time, personalized engagement. Salesforce is leaning into this shift with tools that replace one-way campaigns with dynamic conversations. AI agents now tailor interactions based on behavior, preferences, and real-time context, fostering true customer intimacy at scale.Unified Data Is the Bedrock of Smart AI: No AI strategy can succeed without clean, connected data. Salesforce's Data Cloud addresses what SAP calls the “swivel chair problem” — when teams toggle between disconnected systems to piece together a customer story. AI agents can't operate effectively if data is fragmented or siloed. That's why Salesforce is investing in tools that unify sales, marketing, support, and financial data, giving AI a full-picture view of the customer journey.AI Agents Are Already Delivering Real Results: AI isn't theoretical anymore — it's working in the wild. Bonnie pointed out two standout cases: University of Chicago Medicine and Ford Pro. In healthcare, Agentforce transformed an outdated, frustrating appointment system into a streamlined digital process, improving both efficiency and patient experience. At Ford, AI agents guide customers to ideal vehicle matches with minimal input, keeping users on-site and increasing conversion.The Big Quote: “I think that buyers are looking more at the execution and fit of software, as opposed to the software brand itself. And I would say that that is a shift in the last year or so, especially now with the advent of AI and just the rapid pace that everything is moving so, less on brand, more about how are you going to offer me the complete solution and break down silos of data?” More from Bonnie Tinder:Connect with Bonnie on LinkedIn or send a message via her Acceleration Economy Analyst page. Visit Cloud Wars for more.

What are we sleeping less and less? What are the benefits of getting a good nights sleep and the risks if we consistently don't? How is sleep linked to memory, cognitive performance, blood sugar regulation & stress hormones? How is young people's development affected by sleep?In this episode we have the surprising data on the science of sleep to get up to date on; so, why there's a sleep deprivation epidemic; how sleep works and what it's required for; dreams; and importance of sleep for learning and for immunity. We're also going to discuss the wide range of serious health issues that arise with even a small sleep deficit, and the vast benefits of getting sleep right; and the lifestyle tips we need to consistently get the sleep we need. And of course, sleep and mental health, and the importance of sleep for development in young people.Gratefully our guest today is a psychologist and neuroscientist that specialises in sleep, mental health and dream research, particularly in young people. She's the Scientific Director of Psychology at the University of St. Thomas, Minnesota, Roxanne Prichard! She's the author of over 40 highly citied scientific papers, and her TEDx talk “Addressing our Childrens Sleep Debt” was featured in the lecture series: Transforming Education. She's quoted regularly in the press, inlcuding the New York Times, Wall Street Journal, Teen Vogue, and USA Today.What we discussed:00:00 Intro.05:00 The Sleep deprivation epidemic.07:15 Shaking off prejudice about resting being laziness. 08:31 Glymphatic system for toxin removal.10:00 Synaptic plasticity: Learning & unlearning.11:10 Learning & memory require sleep.14:00 The hippocampus processes memory during sleep.15:00 Late night cramming for exams blocks learning.15:50 Lack of sleep appears to the body as a threat out in the world.17:40 Blood sugar regulation is affected by sleep.18:00 “Sleep! Like diet and exercise only easier!”19:10 Immunity and sleep deprivation.21:00 Cancer & regularity of circadian rhythms.22:00 Evolution, daylight, circadian rhythms & learning.23:45 Sleep delay of morning stress hormones in teens. 26:15 Light Vs Deep ‘Slow Wave' Vs REM sleep.30:00 REM Sleep explained. 33:00 Dreams: The top theories.36:30 The electrical nature of sleep & brain waves.40:00 Alpha Waves and biofeedback for insomnia.42:00 Insomnia & the health risks of sleep deprivation.46:00 Sleep is within our control.47:15 The inflammation link with sleep.49:30 The mental health risks of sleep deprivation. 50:00 Catastrophising and attention deficit.50:45 College students mental health & sleep as a crucial marker.57:30 Persausive technology, screens & sleep.01:02:30 How much sleep do we need? 01:04:25 Avoid external stimulants & go to low light.01:06:00 Avoid internal stimulants like caffeine and alcohol. 01:07:40 Sleep and wake at regular times every day.01:08:40 Core temperature dropping signals sleep.01:10:00 Roxanne's campaign points.01:12:00 The shame around rest. References: Ya Chai at al, ‘Two nights of recovery sleep restores hippocampal connectivity but not episodic memory after total sleep deprivation' paper.https://www.nature.com/articles/s41598-020-65086-xN.I.H. article, 'Sleep on it - How snoozing strengthens memories' (40% drop in learning after sleep deprivation)https://newsinhealth.nih.gov/2013/04/sleep-itU. Chicago Medicine article, 'New study helps explain the link between sleep loss and diabetes'.Trisha Hershey, ‘the Nap' Bishop. - “Rest is Resistance” book.

What happens to the practice of medicine when machines begin to reason, summarize and even empathize — at least in the linguistic sense — better than humans do? In this episode, we meet with Michael Howell, MD, MPH, Chief Clinical Officer at Google, to explore the seismic shifts underway in healthcare as artificial intelligence becomes more deeply embedded in clinical workflows. Dr. Howell, a pulmonary and critical care physician, has spent his career at the crossroads of clinical excellence and systems innovation. Before joining Google, he served as chief quality officer at University of Chicago Medicine. At Google, he leads the development and implementation of AI technologies intended to support scalable, safe and equitable medical care. Over the course of our conversation, we examine what AI is and isn't. We delve into how large language models are reshaping the cognitive labor of clinicians, the implications of machines that may someday outperform humans in diagnosis, and whether there is something inherently human about healing that algorithms will never capture. Along the way, we discuss not only the promises of AI, but also its hidden dangers, ethical landmines, and the enduring question — in a future defined by ever smarter machines. What does it mean to be a good doctor?In this episode, you'll hear about: 2:43 - Dr. Howell's path to medicine and eventually to becoming Chief Clinical Officer at Google 6:45 - Why examining the differences between theory and implementation of technology matters17:35 - The evolution of AI and its clinical capabilities26:05 - The definition of “thinking” in the age of AI36:11 - How AI could change the landscape of healthcare on a global scale50:26 - The ethics of using — and not using — AI in medicine54:36 - The role of a doctor in 20 years Visit our website www.TheDoctorsArt.com where you can find transcripts of all episodes.If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2024

Who is the ultimate candidate for GAE, which technical approach is best, and how do you set your patients up for success? Tune into this week's episode of BackTable to hear from interventional radiologists Dr. Osman Ahmed (University of Chicago Medicine) and Dr. Siddharth Padia (UCLA Health) as they discuss everything from patient selection to follow-up care, covering pre-procedure imaging, access, embolics, technical challenges, clinical data, and the future of genicular artery embolization. --- SYNPOSIS Dr. Ahmed and Dr. Padia debate their approaches to patient selection criteria, the use of MRI and cone beam CT, permanent vs. resorbable embolic materials, how many arteries to embolize, and the relevance of pain metrics post GAE. They also delve into follow-up considerations and the potential for GAE as a long term treatment. --- TIMESTAMPS 00:00 Introduction 01:08 MRI for Patient Selection in GAE 08:53 Access Techniques: Femoral vs. Pedal 17:07 Cone Beam CT in GAE Procedures 27:20 Embolization Strategies 39:30 Challenges and Complications in Embolization 44:50 Follow-Up and Pain Metrics in Clinical Practice and Research 01:06:30 Repeat GAE Procedures: When and Why? 01:11:13 Post-Total Knee Replacement and GAE 01:21:01 Advice for IRs Looking to do GAE 01:24:32 Conclusion and Final Thoughts --- RESOURCES GENESIS Trial: https://pubmed.ncbi.nlm.nih.gov/33474601/ Landers et al Trial: https://pubmed.ncbi.nlm.nih.gov/37051829/

Who is the ultimate candidate for GAE, which technical approach is best, and how do you set your patients up for success? Tune into this week's episode of BackTable to hear from interventional radiologists Dr. Osman Ahmed (University of Chicago Medicine) and Dr. Siddharth Padia (UCLA Health) as they discuss everything from patient selection to follow-up care, covering pre-procedure imaging, access, embolics, technical challenges, clinical data, and the future of genicular artery embolization. --- This podcast is supported by: Guerbet --- SYNPOSIS Dr. Ahmed and Dr. Padia debate their approaches to patient selection criteria, the use of MRI and cone beam CT, permanent vs. resorbable embolic materials, how many arteries to embolize, and the relevance of pain metrics post GAE. They also delve into follow-up considerations and the potential for GAE as a long term treatment. --- TIMESTAMPS 00:00 Introduction 01:08 MRI for Patient Selection in GAE 08:53 Access Techniques: Femoral vs. Pedal 17:07 Cone Beam CT in GAE Procedures 27:20 Embolization Strategies 39:30 Challenges and Complications in Embolization 44:50 Follow-Up and Pain Metrics in Clinical Practice and Research 01:06:30 Repeat GAE Procedures: When and Why? 01:11:13 Post-Total Knee Replacement and GAE 01:21:01 Advice for IRs Looking to do GAE 01:24:32 Conclusion and Final Thoughts --- RESOURCES GENESIS Trial: https://pubmed.ncbi.nlm.nih.gov/33474601/ Landers et al Trial: https://pubmed.ncbi.nlm.nih.gov/37051829/

In today's episode, Dr. Mitchell Posner, Dr. Sarah Shubeck, and Dr. Jelani Williams on the University of Chicago Medicine's new Comprehensive Cancer Center. Scheduled to open in 2027, the new center is a seven-floor, 575,000-square-foot building planned to have 80 private beds and 90 consultation and outpatient rooms. At the moment, the center is anticipated to see 200,000 outpatient visits and 5000 inpatient admissions annually. This would be the city of Chicago's first freestanding cancer pavilion.How will we ensure that this new center prioritizes the community's needs? In Chicago's South Side, cancer death rates are twice the national average, and cancer is also the second-leading cause of death on the South Side behind heart disease. In this conversation, you'll hear about the center's development, what patients can expect, and most importantly, the Department of Surgery's commitment to ensure the cancer center supports those who are most vulnerable. Dr. Mitchell Posner is the Thomas D. Jones Distinguished Service Professor of Surgery, Chief of the Section of General Surgery, and the Chief Clinical Officer of the University of Chicago Medicine Comprehensive Cancer Center. From clinical trials for cancer treatment to his more than 250 articles, abstracts, and book chapters, Dr. Posner is a leading authority in the management of upper gastrointestinal cancers. He is frequently voted among the country's best doctors. He is the past president of the Society of Surgical Oncology. He is deputy editor of the Annals of Surgical Oncology and section editor for the gastrointestinal cancer section of the journal Cancer. He served as chairman of the Gastrointestinal Committee of the American College of Surgeons Oncology Group (ACOSOG).Dr. Sarah Shubeck is an Assistant Professor in the Department of General Surgery. She is a Breast Surgical oncologist specializing in breast surgery, cancer, and benign disease treatment. In addition to her clinical practice, Dr. Shubeck's research has been published in many journals including Cancer, JAMA Surgery, and Annals of Surgical Oncology.Dr. Jelani Williams is a 5th-year general surgery resident at the University of Chicago. He is an aspiring surgical oncologist and attended the Eastern Virginia Medical School. He has published research on predictive models and surgery for metastatic pancreatic neuroendocrine tumors as well as the use of machine learning to distinguish benign and malignant thyroid nodules amongst other topics. Deep Cuts: Exploring Equity in Surgery comes to you from the Department of Surgery at the University of Chicago, which is located on Ojibwe, Odawa and Potawatomi land.Our executive producer is Tony Liu. Our senior producers are Alia Abiad, Caroline Montag, and Chuka Onuh. Our production team includes Megan Teramoto, Ria Sood, Ishaan Kumar, and Daniel Correa Bucio. Our senior editor and production coordinator is Nihar Rama. Our editorial team also includes Beryl Zhou and Julianna Kenny-Serrano. The intro song you hear at the beginning of our show is “Love, Money Part 2” from Chicago's own Sen Morimoto off of Sooper Records. Our cover art is from Leia Chen.A special thanks this week to Dr. Jeffrey Matthews — for his leadership, vision, and commitment to caring for the most vulnerable in our communities. Let us know — what have you most enjoyed about our podcast. Where do you see room for improvement? You can reach out to us on Instagram @deepcutssurgery. Find out more about our work at deepcuts.surgery.uchicago.edu.

In today's episode, we invited experts from across oncology specialties to discuss the long-term effects of the COVID-19 pandemic—the onset of which occurred 5 years ago. Our guests shared how the pandemic's lingering effects continue to shape patient care. We heard from:  Ramez N. Eskander, MD, a gynecologic oncologist and assistant professor of obstetrics, gynecology, and reproductive sciences at the University of California San Diego Health Rachel N. Grisham, MD, an associate attending physician at Memorial Sloan Kettering Cancer Center in New York, New York Benjamin Herzberg, MD, an assistant professor of medicine at Columbia University Medical Center and an oncologist at Herbert Irving Comprehensive Cancer Center in New York, New York  Kelly McCann, MD, PhD, an assistant professor and breast medical oncologist at UCLA Health's David Geffen School of Medicine in Los Angeles, California Gregory Roloff, MD, a hematologist/oncologist at the University of Chicago Medicine in Illinois

This episode, recorded live at the Becker's Healthcare 12th Annual CEO + CFO Roundtable, features Mark Helms, Executive Director of Strategy & Analytics at the University of Chicago Medicine. Mark shares insights on navigating healthcare strategy in 2025, balancing cybersecurity investments with growth initiatives, and leveraging AI for predictive analytics and operational efficiency. In collaboration with R1.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Husam Balkhy, Professor of Surgery and the Director of Robotic and Minimally Invasive Cardiac Surgery at University of Chicago Medicine and President of The International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), about robotic totally endoscopic cardiac surgery procedures. They discuss potential ways to get the world to perform more robot-assisted surgeries, the building blocks to learning robotics, the future of learning robotics, and what to expect this year at the ISMICS 2025 Annual Meeting. They also explore Dr. Balkhy's new President's Series on CTSNet and provide insights into the first video of this series. Joel also highlights some of the videos in the CTSNet Resident Video Competition and the robotics vs VATS debate in Britain.   Joel also reviews recent JANS articles on the impact of restricted chests on long-term lung function parameters following lung transplantation in patients with interstitial lung disease, determinants of inadequate cardioprotection in adult patients with left ventricular dysfunction, engineered heart muscle allografts for heart repair in primates and humans, and risk factor analysis for 30-day mortality after surgery for infective endocarditis.  In addition, Joel explores open repair of descending thoracic and thoracoabdominal aortic aneurysms, totally 3D endoscopic third tricuspid valve replacement, and how to use the Impella for on-pump CABG in patients with low EF. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) The Impact of Restricted Chests on Long-Term Lung Function Parameters Following Lung Transplantation in Patients With Interstitial Lung Disease    2.) Determinants of Inadequate Cardioprotection in Adult Patients With Left Ventricular Dysfunction  3.) Engineered Heart Muscle Allografts for Heart Repair in Primates and Humans  4.) Risk Factor Analysis for 30-Day Mortality After Surgery for Infective Endocarditis   CTSNET Content Mentioned  1.) Open Repair of Descending Thoracic and Thoracoabdominal Aortic Aneurysms  2.) Totally 3D Endoscopic Third Tricuspid Valve Replacement  3.) ICC 2024 | How I Use the Impella for On-Pump CABG in Patients With Low EF: Insertion, Intraoperative Management, and Weaning/Removal  Other Items Mentioned  1.) President's Series With Husam Balkhy | ISMICS President   2.) ISMICS 2025 Annual Meeting   3.) Career Center   4.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Dr. Andrea King (University of Chicago Medicine) joins AJP Audio to discuss a novel, real time assessment of the reward, stimulation, and negative affect of alcohol use in people with alcohol use disorder with and without depressive disorders.  Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the February issue, which focuses closely on issues surrounding addiction. 00:35     King interview 00:45     Allostatic model of addiction 02:12     Gathering data and the groups studied 07:37     The ethics of studying alcohol use in patients with AUD 10:38     Findings 13:29     The impacts of alcohol's pleasurable effects on people with AUD and those without 14:32     Limitations of natural environment research versus laboratory research 18:18     Clinical implications 20:09     Further research 22:56     Kalin interview 23:03     King et al. 26:21     Brand et al. 28:12     Conway et al. 32:17     Kypriotakis et al. 35:42     Kuhn et al. 39:37     Grilo et al. Transcript Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org

Trauma surgeon and professor Dr. Brian H. Williams has seen it all: gunshot wounds, stabbings, and traumatic brain injuries. Dr. Williams is also an Air Force Academy graduate, a Harvard-trained physician, a former congressional health policy advisor, and a nationally recognized leader at the intersection of public policy and structural racism, gun violence, and health equity. He has treated gun violence victims for more than two decades.rnrnIn his new book The Bodies Keep Coming, Williams ushers us into the trauma bay, where the wounds of a national emergency amass. He draws a through line between white supremacy, gun violence, and the bodies he tries to revive, and he trains his surgeon's gaze on the structural ills that manifest themselves in the bodies of his patients.rnrnWilliams has also served as a Robert Wood Johnson Foundation Health Policy Fellow at the National Academy of Medicine and as a professor of trauma and acute care surgery at the University of Chicago Medicine. Williams and his work have been featured in outlets like the Chicago Tribune, Dallas Morning News, CNN, and Newsweek.

In this episode of Advancing Health Equity, Dr. Maia Hightower, CEO of Equality AI and former Chief Digital Transformation Officer at the University of Chicago Medicine, joins Steven Collens, CEO of MATTER, to explore the transformative role of AI in advancing health equity. With over 20 years of experience in medicine and healthcare leadership, Dr. Hightower shares her expert insights on how artificial intelligence can address disparities and improve patient outcomes. From her time practicing medicine to shaping digital health strategies, she provides a compelling perspective on leveraging technology to create a more equitable healthcare system. Don't miss this thought-provoking discussion on innovation and inclusion.About Advancing Health EquityMATTER's Advancing Health Equity podcast series focuses on unpacking the complexities of health inequities impacting the healthcare system and the health and well-being of individuals and their communities. These 20-30 minute interview-style sessions are meant to take quick dives into critical areas of health equity and answer questions like:What does health equity mean today?Where do current gaps exist in the various areas of healthcare?Where do we see intersections in care?How can technology and innovation be leveraged strategically to positively make a change?For more information, visit matter.health and follow us on social: LinkedIn @MATTERTwitter @MATTERhealthInstagram @matterhealth

Discover the intricate world of celiac disease with insights from two esteemed GI dietitian experts, Nick Trott of the Royal Hallamshire Hospital in Sheffield, England and Lori Welstead, from the University of Chicago Medicine. Within minutes of this episode beginning, you learn that a celiac diagnosis can happen in the absence of noticeable GI symptoms and that it is possible to find great delicious gluten-free meals outside your home with some tips and tricks! Kate, Dr. Riehl and their guests highlight the challenges and triumphs of living gluten-free head-on, unraveling common misconceptions surrounding gluten-related symptoms and the necessity of gluten-free diets. We shed light on personal stories of dietary transitions (and the often undiscussed topic of food shaming), the grief of losing gluten, and the resilience needed to embrace a new lifestyle. While there can be emotional and nutritional challenges that accompany this diagnosis, you will feel validated and hopeful throughout this episode as you hear the latest research advancements and the evolving landscape of celiac disease management.  You are in for a gluten-free treat with Episode 10 as it is packed with practical guidance, hot off the press science and expert insights for anyone touched by or interested in celiac disease.Helpful information and resourcesInformation on the drug development pipeline:https://www.beyondceliac.org/research/drugdevelopment/drug-development-pipeline/Learn about the clinical trial process:https://www.beyondceliac.org/wp-content/uploads/2020/10/Clinical-Trial-Process-Infographic-from-Beyond-Celiac.pdfThe Dating and Celiac Disease StudyLebovits J, Lee AR, Ciaccio EJ, Wolf RL, Davies RH, Cerino C, Lebwohl B, Green PHR. Impact of Celiac Disease on Dating. Dig Dis Sci. 2022 Nov;67(11):5158-5167.https://pubmed.ncbi.nlm.nih.gov/35635630/ Restaurant finding app: Find Me Gluten Free America's Test Kitchen book: How Can it Be Gluten-Free Podcast and documentary: The Celiac ProjectThird party testing: Gluten Free WatchdogThank you to Zego Foods for the sponsorship of this episode. Learn more about Kate and Dr. Riehl:Website: www.katescarlata.com and www.drriehl.comInstagram: @katescarlata @drriehl and @theguthealthpodcastOrder Kate and Dr. Riehl's book, Mind Your Gut: The Science-Based, Whole-body Guide to Living Well with IBS. The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

Steve Grzanich has the business news of the day with the Wintrust Business Minute. A $75 million donation from the AbbVie Foundation will help University of Chicago Medicine build its new cancer hospital on Chicago’s south side. The new building will be called the AbbVie Foundation Center Cancer Pavilion and has a completion date in […]

Jason Xiao, BS, recaps his article, “Improving the Affordability of Glaucoma Medications,” which was written with Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD, and featured in the May/June issue of Glaucoma Today. Their article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients' out-of-pocket pharmacy costs.

Episode Resources:Ostomy Care Management (OCM) ProgramThe Wound, Ostomy, and Continence Nurses Society™ (WOCN®) SocietyThe American Society of Colon and Rectal Surgeons (ASCRS) About the Guests:Jan Colwell, APRN, CWOCN, FAAN, is an advanced practice nurse certified in wound ostomy and continence care. She most recently practiced at the University of Chicago Medicine providing care to patients with ostomies. She is a past president of the WOCN Society and Friends of Ostomates Worldwide USA, and has contributed to ostomy patient care by editing several ostomy care text books, participated in ostomy research projects, authored multiple ostomy based articles and is the co-section editor of the ostomy section of the Journal of Wound, Ostomy, and Continence Nursing (JWOCN®).Bethany Malone, MD, is a board-certified colon and rectal surgeon based in Fort Worth, TX. She practices broad-based colorectal surgery including screening colonoscopies and treats benign anorectal conditions, hemorrhoids, fecal incontinence, colon cancer, rectal cancer, and inflammatory bowel disease. Dr. Malone is an active member of the American Board of Colon and Rectal Surgeons, the American College of Surgeons, and the International Society of University Colon and Rectal Surgeons.Jenny Speranza, MD, attended the Rochester Institute of Technology, graduating in 1994 with her B.S. degree, Magna Cum Laude. She earned her M.D. from the School of Medicine, State University of New York at Buffalo (1999). Dr Speranza finished her surgical residency in 2004 from the State University of New York at Buffalo Consortium. In 2005, she completed a Colon and Rectal fellowship at the University of Miami. Prior to arriving at the University of Rochester, Dr. Speranza was on staff at the Cleveland Clinic Florida where she was an attending surgeon in the department of Colon and Rectal Surgery. Dr. Speranza is a member of American College of Surgeons, the American Society of Colon and Rectal Surgeons, and serves on two committees of the Society of American Gastrointestinal and Endoscopic surgeons.

October is Breast Cancer Awareness Month. The Director of Clinical Cancer Genetics and Global Health at The University of Chicago Medicine, Dr. Funmi Olopade, talks about the latest research in breast cancer treatment and how Black women can recover and heal.

Our next guest is Kyle Swinsky, CEO of AMOpportunities. Kyle leads a company that helps medical trainees, students, and international graduates secure rotations in the US. Kyle's company mission is to help improve the US health system by unveiling the importance of foreign-trained physicians and the impact of US clinical experiences for international medical students/graduates across the world.   Kyle Swinsky is the co-founder and CEO of AMOpportunities, a Chicago-based company that helps international medical students and graduates secure U.S. rotations and supports hospitals and schools in managing trainees through high-quality services and software solutions.   Connect with Kyla and AMOpportunities Here https://www.linkedin.com/in/kyleswinsky/ https://amopportunities.org/ https://www.youtube.com/channel/UC-xw8Mr2bu7bvD6PTezy0YQ In 2013, Kyle, along with co-founder and COO Ben Bradley, launched AMOpportunities to make U.S. clinical experiences accessible to medical trainees around the world. Since 2013, AMO has tripled in size, raised $8.9 million in funding, won the President's “E” Award for Exports and PIEoneer of the Year, and helped more than 3,600 trainees rotate in the U.S.   The company counts Kaplan Medical and AMSA as partners as well as institutions such as University of Miami, Chicago Medicine, MedStar Georgetown University Hospital, and Florida International University.   © Concierge Medicine Today, LLC. ("CMT") All rights reserved.   Disclaimers: All content presented here is for general information purposes only. It is NOT intended to provide medical, legal, professional, accounting or financial advice. No warranties or guarantees are assumed or implied and user(s) releases Concierge Medicine Today, LLC, its agents, representatives, affiliated brands/companies and/or guests from all damages, liability and/or claims. Be advised, some references, companies, individuals, products, services, resources and/or links may be out-of-date. Concierge Medicine Today, LLC does not update content past its release date. User(s) assume all risk and liability with any use of the content as well as third party links. Concierge Medicine Today, LLC., has no formal peer review and, therefore, cannot guarantee the validity of information and/or content contained on its web sites, podcasts, and/or all content it produces or releases. While some of our speakers may be licensed Physicians, they are not your Physician. Please consult your Physician related to anything you may have read or heard or have questions about or call 911. The views, thoughts, and opinions expressed are the speaker's own and do not necessarily represent the views, thoughts, and/or opinions of Concierge Medicine Today, LLC. The "Concierge Medicine Today, LLC" ("CMT") name and all forms and abbreviations are the property of its owner and its use does not imply endorsement of or opposition to any specific organization, product, or service. Additional disclaimers, releases, terms of use and conditions apply also to the production and/or use of this content, https://conciergemedicinetoday.org/tcpp/.

Episode Resources:For resources mentioned in this episode, including organizations where you can donate unused ostomy supplies, visit the links below:Friends of Ostomates Worldwide-USA (FOW)Friends of Ostomates Worldwide (Canada) (FOWC)United Ostomy Associations of America (UOAA) Support Group finderAmerican Cancer SocietyUSC Center for Inflammatory Bowel Disease About the Speaker:Janice Colwell, APRN, CWOCN, FAAN, is an advanced practice nurse certified in wound ostomy and continence care. She most recently practiced at the University of Chicago Medicine providing care to patients with ostomies. She is a past president of the WOCN Society and Friends of Ostomates Worldwide USA, and has contributed to ostomy patient care by editing several ostomy care textbooks, participating in ostomy research projects, authoring multiple ostomy-based articles, and is the co-section editor of the ostomy section of the Journal of Wound, Ostomy, and Continence Nursing (JWOCN).

Also in the news: Illinois democrat says Biden should take time to consider running; University of Chicago Medicine employees ready to strike; Son of former football player found safe, parents in custody and more.

Also in the news: Illinois democrat says Biden should take time to consider running; University of Chicago Medicine employees ready to strike; Son of former football player found safe, parents in custody and more.

Also in the news: Illinois democrat says Biden should take time to consider running; University of Chicago Medicine employees ready to strike; Son of former football player found safe, parents in custody and more.

Recorded at the first annual “HemOnc Pulse” Live meeting, this episode features a panel discussion on unanswered questions in myeloproliferative neoplasms (MPN) with Naveen Pemmaraju, MD, of the University of Texas MD Anderson Cancer Center; Ruben Mesa, MD, of the Atrium Health cancer service line; Sanam Loghavi, MD, of the MD Anderson Cancer Center; and Olatoyosi Odenike, MD, of the University of Chicago Medicine.

Forty-five years after a Chicago hospital pioneered an integrated network strategy, the healthcare landscape has undergone a significant shift towards prioritizing preventative care. In this episode of Value-Based Care Insights, Jeffry Peters, an expert on medical group strategy, along with Michael Antoniades, President of the University of Chicago Medicine, explore the groundbreaking challenges and strategies that revolutionized healthcare delivery, and how they are still being tackled today. Gain insights on the evolving focus towards preventative care, the measures used to evaluate healthcare delivery, and the pivotal role of primary care in bolstering the entire healthcare ecosystem. --- Send in a voice message: https://podcasters.spotify.com/pod/show/lumina-health-partners/message

Steve Grzanich has the business news of the day with the Wintrust Business Minute. University of Chicago Medicine’s new facility in Crown Point opens today. It’s UChicago’s first freestanding facility in Indiana and it’s largest offsite location, located near I-65 and 109th Avenue. UChicago Medicine Crown Point will offer advanced specialty care including cancer, heart, […]

Forty-five years after a Chicago hospital pioneered an integrated network strategy, the healthcare landscape has undergone a significant shift towards prioritizing preventative care. On this episode Jeffry Peters, an expert on medical group strategy, along with Michael Antoniades, President of the University of Chicago Medicine, explore the groundbreaking challenges and strategies that revolutionized healthcare delivery, and how they are still being tackled today. Gain insights on the evolving focus towards preventative care, the measures used to evaluate healthcare delivery, and the pivotal role of primary care in bolstering the entire healthcare ecosystem. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Also in the news: 22-year-old man accused of killing 4 people, injuring 7 in Rockford; Avondale Korean American restaurant sort of returning after closing; University of Chicago Medicine interns, residents to unionize and more.

Steve Grzanich has the business news of the day with the Wintrust Business Minute. University of Chicago Medical Center medical residents and fellows are forming a union. More than 1,000 of them have announced plans to join the Committee of Interns & Residents, a division of Service Employees International Union. They’ve filed a petition for […]

Also in the news: 22-year-old man accused of killing 4 people, injuring 7 in Rockford; Avondale Korean American restaurant sort of returning after closing; University of Chicago Medicine interns, residents to unionize and more.

Laura Sage, the founder of the Lynn Sage Breast Cancer Foundation, joins Lisa Dent to discuss how the University of Chicago Medicine, RUSH University for Health, and Northwestern Medicine all came together to launch the Chicago Breast Cancer Research Consortium as a way to increase access to clinical trials for breast cancer research. Follow The Lisa […]

Weight gain is a common complaint among women in their 40s and 50s, with many blaming it on the ups and downs of menopause. But what exactly is the connection between menopause and weight gain? And can anything to be done to avoid it? In this episode, Sanjay speaks to Dr. Monica Christmas, the director of the menopause program at the University of Chicago Medicine and an associate professor of obstetrics and gynecology. She explains effective strategies for tackling midlife weight gain and shares practical advice on navigating this transformative phase with grace. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: How can we expand clinical education to develop the healthcare workforce we desperately need?According to our next guest, Kyle Swinsky, co-founder and CEO of AMOpportunities, it starts by equipping universities and healthcare providers with scalable infrastructure.Drawing from a passion to increase opportunities for international medical trainees, Kyle built a workforce solution that matches students to hands-on rotations while supporting host sites through technology and services.While together, we explore AMO's mission to address bottlenecks preventing schools from graduating qualified healthcare professionals and Kyle reveals how his company augments limited teaching capacity, facilitates ideal student-site relationships, and drives strategic growth into allied health fields.Join us to hear how Kyle and the AMO team is successfully expanding clinical education to develop healthcare's workforce! Let's go! Episode Highlights:AMO bridges clinical education gaps by matching students to hands-on training opportunitiesTheir platform and services augment limited teaching capacity at hospitals/clinicsStudents get experience where they want while sites gain pipeline of future workforceAMO has helped over 5,500 trainees secure rotations to advance their careersStrategic growth planned for nursing, PA, rehab therapy, and other allied health fieldsAbout our Guest: Kyle Swinsky is the co-founder and CEO of AMOpportunities, a Chicago-based company that helps international medical students and graduates secure U.S. rotations and supports hospitals and schools in managing trainees through high-quality services and software solutions.In 2013, Kyle, along with co-founder and COO Ben Bradley, launched AMOpportunities to make U.S. clinical experiences accessible to medical trainees around the world. Since 2013, AMO has tripled in size, raised $8.9 million in funding, won the President's “E” Award for Exports and PIEoneer of the Year, and helped more than 3,600 trainees rotate in the U.S. The company counts Kaplan Medical and AMSA as partners as well as institutions such as University of Miami, Chicago Medicine, MedStar Georgetown University Hospital, and Florida International University.Links Supporting This Episode:AMOpportunities Website: CLICK HEREKyle Swinsky LinkedIn page: CLICK HEREKyle Swinsky Twitter page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Betel quid chewing, a traditional custom widely practiced in South Asia, Southeast Asia, the Asia-Pacific region, and East Africa for centuries, involves the consumption of raw areca nut mixed with slaked lime and wrapped in a betel leaf. This habit is particularly popular in certain regions, including Northeast India, where the areca nut is raw, wet, and consumed unprocessed. The act of chewing and swallowing this mixture leads to the release of alkaloids, polyphenols, and tannins. However, the consumption of raw areca nut betel quid has been strongly associated with the development of oral, esophageal, and gastric cancers, and has adverse consequences on oral health. Several studies have shown a significant relationship between periodontitis and betel quid chewing habits in many countries, including India. In this context, esophageal cancer is a devastating disease that affects millions of people around the world. Recent research has shed light on the role of the Mad2 gene in the development and progression of esophageal cancer, a disease strongly associated with the consumption of raw areca nut betel quid. In a new study, researchers Chongtham Sovachandra Singh, Nabamita Boruah, Atanu Banerjee, Sillarine Kurkalang, Pooja Swargiary, Hughbert Dakhar, and Anupam Chatterjee from The Assam Royal Global University, University of Pennsylvania, LN Mithila University, University of Chicago Medicine, Nazareth Hospital, Laitumkhrah, and North-Eastern Hill University provide valuable insights into the molecular mechanisms underlying Mad2 gene deregulation in esophageal cancer. On February 5, 2024, their new research paper was published in Oncotarget's Volume 15, entitled, “Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples.” Full blog - https://www.oncotarget.org/2024/02/22/raw-areca-nut-betel-quid-consumption-and-esophageal-cancer/ Paper DOI - https://doi.org/10.18632/oncotarget.28554 Correspondence to - Anupam Chatterjee - achatterjee@rgu.ac, chatterjeeanupam@hotmail.com Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28554 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, Mad2 gene, histone methylation, histone acetylation, Rb-phosphorylation; esophageal cancer About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

BUFFALO, NY- February 12, 2024 – A new research paper was published in Oncotarget's Volume 15 on February 5, 2024, entitled, “Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples.” Raw areca nut (AN) consumption increases esophageal squamous cell carcinoma (ESCC) due to overexpression of securin (pituitary tumor transforming gene1), causing chromosomal instability. Mitotic arrest deficient protein 2 (Mad2), a crucial spindle assembly checkpoint protein, is at risk of aneuploidy and tumor development when overexpressed or underexpressed. In this new study, researchers Chongtham Sovachandra Singh, Nabamita Boruah, Atanu Banerjee, Sillarine Kurkalang, Pooja Swargiary, Hughbert Dakhar, and Anupam Chatterjee from The Assam Royal Global University, University of Pennsylvania, LN Mithila University, University of Chicago Medicine, Nazareth Hospital, Laitumkhrah, and North-Eastern Hill University evaluated Mad2 status in human ESCC with AN consumption habits, revealing unclear molecular mechanisms. Human ESCC samples (n = 99) were used for loss of heterozygosity analysis at 4q25-28, while 32 samples were used for expression analysis of Mad2, E2F1 genes, and Rb-phosphorylation. Blood samples were used for metaphase preparation. The Mad2 deregulation was assessed using chromatin immunoprecipitation-qPCR assay in the core promoter region, establishing its association with the pRb-E2F1 circuit for the first time. “The study revealed overexpression and underexpression of Mad2, premature anaphase, and chromosome missegregation in all the samples.” LOH pattern identified a deletion in D4S2975 in 40% of ESCC samples. The study reveals the deregulation of pRb-E2F1 circuit in all samples. 4q27 disruption could be a factor for Mad2 underexpression in AN-induced esophageal carcinogenesis, while overexpression may be due to the deregulation of the Rb-E2F1 circuit and consequently elevation of H3K4me3 and H3K9ac. “Mad2 expression levels with chromosomal abnormalities can be a clinical biomarker, but further research is needed to understand pRb's role in Mad2 down-regulation.” DOI - https://doi.org/10.18632/oncotarget.28554 Correspondence to - Anupam Chatterjee - achatterjee@rgu.ac, chatterjeeanupam@hotmail.com Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28554 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, Mad2 gene, histone methylation, histone acetylation, Rb-phosphorylation; esophageal cancer About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

Advanced computing and communications technologies offer tremendous promise for patient care, but turning that promise into reality requires high levels of specialized expertise that health systems just don't have in-house.But some hospitals, like Boston's Children's –seem to have figured it out. How do they do it?TOPICS(0:44) Tracing the career of Pixel Health CEO Michael Feld (3:09) The structure and symbolism of Pixel Health(9:23) What are the current challenges in healthcare and what role does technology play in addressing them? (11:03) Pixel Health's involvement with Boston Children's Hospital(18:08) What is the promise of 5G in healthcare?(21:22) What is a hybrid 5G network?(25:51) How will privacy and security be affected by these hybrid networks?(31:12) What comes next for the healthcare industry, Pixel Health and technology

No matter your specialty, you must be valuable to your patients. You know that. What many practice owners under-appreciate is that they must also be different than their competition. Why? Patients have choices. Why should they choose you?  Founder of Harper Health, Dr. Will is in his 25th year as an internal medicine physician in Chicago. Prior to founding Harper Health, he held a number of different roles as a physician-leader, including developing a number of core courses at the University of Chicago medical school, directing of the executive physical practice at the University of Chicago Medicine for more than 15 years and co-founding/running a successful wellness coaching business from 2009-2015. In this episode Carl White and Will Harper discuss:Why most doctors find it difficult to grasp what a good difference isWho Dr. Will considers his competition to beHow Dr. Will makes his difference better and stronger over time Want to be a guest on PracticeCare?Have an experience with a business issue you think others will benefit from? Come on PracticeCare and tell the world! Here's the link where you can get the process started. Connect with Will Harperhttps://www.harper-health.com/ Connect with Carl WhiteWebsite: http://www.marketvisorygroup.comEmail:  whitec@marketvisorygroup.comFacebook:  https://www.facebook.com/marketvisorygroupYouTube: https://www.youtube.com/channel/UCD9BLCu_i2ezBj1ktUHVmigLinkedIn: http://www.linkedin.com/in/healthcaremktg 

Welcome to our 100th episode! This week we talked to the renowned Dr. David T. Rubin! Dr. Rubin is the Joseph B. Kirsner Professor of Medicine and a Professor of Pathology, Chief of the Section of Gastroenterology, Hepatology & Nutrition and the Co-Director of the Digestive Diseases Center at The University of Chicago Medicine. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics, an associate investigator at the University of Chicago Comprehensive Cancer Center and is a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He is the chair of the National Scientific Advisory Committee of the Crohn's & Colitis Foundation, where he also serves as a Board of Trustees member. He is the deputy chair of the Executive Committee of the International Organization for the Study of Inflammatory Bowel Disease.  In 2018, Dr. Rubin completed the Harvard T.H. Chan School of Public Health Leadership Development Course for Physicians.Dr. Rubin is a Fellow of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE), the American College of Physicians (ACP), and the Royal College of Physicians (Edinburgh). He is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America's Top Physicians (gastroenterology). Additionally, he twice received the ACG's Governor's Award of Excellence in Clinical Research (2003 and 2013), and the UChicago Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the Crohn's & Colitis Foundation's Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families. He is an Associate Editor of the journal Gastroenterology and Editor-in-Chief of the ACG On-Line Education Universe. In 2020, Dr. Rubin received the Sherman Prize for Excellence in Crohn's and Colitis.Dr. Rubin is an editor of a best-selling book Curbside Consultation in IBD which is now in its 3rd edition and an author or coauthor of over 500 articles on treatment and management of IBD, cancer in IBD and novel paradigms, as well as the first author of the 2019 ACG Guidelines for ulcerative colitis. His current research is in the area of novel approaches to monitoring of IBD (wearables and point of care intestinal ultrasound), prevention of progressive complications from uncontrolled inflammation, and a variety of collaborative and translational studies related to the causes of IBD and its complications. Episodes from some of Dr. Rubin's UChicago's team: Dr. Alysse Bedell- Gastro PsychologistMichele Rubin, APN- JPouch surgical nurse extraordinaireMarita Kametas- Ostomy Specialist! Dr. David Choi- IBD PharmacistPlease keep in mind that the views and opinions expressed in this program are those of the speakers and should not be considered medical or legal advice. Please consult with your healthcare team on any changes to your disease, diet, or treatment.Let's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

On this edition of Score Values, Alex Kuhn is joined by Michael Nameche, who's the executive director of the Chicago Coalition for the Homeless. Later, Janae Rhodes, the nurse supervisor for the University of Chicago Medicine's Family Connects program, joins the show.

This week we spoke to Michele Rubin! Michele is an advanced practice nurse and is the Associate APN Director of the IBD Center at the University of Chicago Medicine. She specializes in surgery for IBD and has helped to create a J-Pouch specific clinic. We talked to her about surgery part of the treatment options, J-Pouches and what to expect in recovery, and how she works with patients to ensure they have the best outcomes. We also discussed the research that she's done related to IBD surgery and their efforts to try to predict a patient's response to their J-Pouch and how to treat complications. Finally we talked about how and why a surgeon may choose to hand sew instead of use surgical staples. Michele has been in the IBD space for a long time and has so much knowledge to share and she was such a joy and a light. We could have talked to her for hours. Please keep in mind that the views and opinions expressed in this program are those of the speakers and should not be considered medical or legal advice. Please consult with your healthcare team on any changes to your disease, diet, or treatment. We want you to stay safe and healthy! ;) Let's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Meet Dr. Brian H. Williams, a distinguished trauma surgeon and author of The Bodies Keep Coming: Dispatches from a Black Trauma Surgeon on Racism, Violence, and How We Heal.   In this episode, Diverse host David Pluviose engages in a conversation with the Air Force Academy graduate and Harvard University-trained surgeon on the intersection between public policy and critical issues like structural racism, gun violence, and health equity.   Williams is a professor specializing in trauma and acute care surgery at the University of Chicago Medicine. His impactful work and insights have garnered recognition worldwide. With over two decades of expertise in treating victims of gun violence, Williams has also served as a Robert Wood Johnson Foundation Health Policy Fellow at the National Academy of Medicine.   Explore Williams' remarkable journey, from the trauma bay to his current political campaign, as he passionately discusses solutions to address systemic issues, healthcare disparities, and the ongoing struggle for justice. We also dive deep into the emotional aftermath of the Dallas mass shooting, a pivotal moment that ignited Williams' commitment to broader societal healing.   So, join Pluviose and Williams in this thought-provoking discussion about transformative healing.   *As a bonus to this episode Williams has graciously offered one podcast listener a free signed copy of his book. To be eligible, let us know you have listened and share feedback @DiverseIssues on X (formerly Twitter). We want to hear from you by Dec. 31. Enjoy!   KEY POINTS:   - Williams' reflection on how the Dallas mass shooting served as his career's pivotal moment - The importance of having a personal healing journey - The impact of witnessing gun violence firsthand as a trauma surgeon - A glimpse into the writing process for The Bodies Keep Coming: Dispatches from a Black Trauma Surgeon on Racism, Violence, and How We Heal  - Identification of strategies to create a system change, uplift the community, and address healthcare disparities - Factors that led to Williams' pursuing a candidacy in the Congress - How journaling can help in processing one's emotions  - The importance of empathy and understanding in the face of tragedy - William's advocacy for gun safety policies   QUOTABLES:   “I say this frequently. I didn't choose trauma surgery; trauma surgery chose me.” – Dr. Brian Williams   "We have a majority of Americans that want to do something to reduce needless death and suffering due to firearms." – Dr. Brian Williams   GUEST RESOURCES:   Dr. Brian Williams    Website: https://brianwilliamsmd.com/ X (formerly Twitter): @bhwilliamsmd LinkedIn: @bhwilliamsmd Instagram: @BrianHWilliamsMD   Book: The Bodies Keep Coming: Dispatches from a Black Trauma Surgeon on Racism, Violence, and How We Heal. To purchase, go to https://www.broadleafbooks.com/store/product/9781506483122/The-Bodies-Keep-Coming    OR FOLLOW US ON SOCIAL MEDIA: X (formerly Twitter): http://twitter.com/diverseissues Instagram: http://instagram.com/diverseissuesinhighereducation Facebook: http://facebook.com/DiverseIssuesInHigherEducation/ Linkedin: http://linkedin.com/company/diverse-issues-in-higher-education   WATCH THIS VIDEO AND OTHERS ON OUR YOUTUBE CHANNEL: https://www.youtube.com/@DiverseIssuesInHigherEducation  Closed captioning and live show transcription are available in the video for this episode.

What do you call NETs in the liver? How often do NETs spread? What causes NETs to spread? How do you determine if surgery is an option? Dr. Xavier Keutgen from University of Chicago brings clarity to NET tumors found in the liver and describes how surgery fits in with other treatments for metastatic NETs.ABOUT DR. XAVIER KEUTGENXavier M. Keutgen MD is a board-certified, double-fellowship trained surgeon who specializes in the treatment of gastro-entero-pancreatic neuroendocrine tumors and neoplasms of the thyroid-, parathyroid- and adrenal glands. A native from Belgium, Dr. Keutgen graduated magna cum laude from the University of Heidelberg Medical School in Germany and completed a general surgery residency and surgical oncology research fellowship at New York Presbyterian Hospital-Weill Cornell Medical Center.  He then completed a hepato-pancreato-biliary fellowship at the University Hospital of Zurich in Switzerland as well as an endocrine oncology and surgery fellowship at the National Cancer Institute, National Institutes of Health (NIH) in Bethesda, Maryland. Dr. Keutgen currently serves as the director of the Neuroendocrine Tumor Program, director of the Endocrine Research Program and co-director of the Von Hippel-Lindau Clinical Care Program at the University of Chicago Medicine.Throughout his career Dr. Keutgen has developed a particular interest in clinical, translational and basic science research. His laboratory specializes in investigating the role of radiation therapy and DNA damage repair in pancreatic, lung and small bowel neuroendocrine tumors, discovering new actionable molecular targets for neuroendocrine tumors, and elucidating new mechanisms of drug delivery for endocrine malignancies.TOP TEN QUESTIONS What is liver NETs? How often do NETs spread? Is it expected that NETs will eventually spread?If the primary tumor was already removed, do you now call this liver NET or do you still refer to it by the primary site of origin – and why? How is this different from liver cancer?What causes NETs to spread? Is there anything that is done to cause NET tumors to spread? Is there anything that can be done to keep them from spreading?How do you determine if surgery is an option? What is involved in evaluating metastases? What scans or labs are needed?How do you decide what the “tumor burden” is?How do you weigh the grade or ki67?  How do you weigh tumor size? Is there a cut-off for tumor size or the number of tumors that is too much to operate?How does one decide between surgery versus other options? How often can surgery or other treatments be done? How safe is liver surgery?How do you approach surgery for someone with liver tumors who also has tumors in the tail versus the head of the pancreas?When someone has had a Whipple surgery and later is found to have tumors in the liver, what are the options?What advances in the field are you most excited about? For more information, visit LACNETS.org.

In this episode, Matt sits down with Christos Lazaridis (University of Chicago Medicine) to chat about what brain death is and whether brain death should count as, like, death death.Modern life support technology really hits its stride in the 1960s, allowing doctors to buy themselves more time to save their patients by connecting them to machines that can assist with breathing, blood oxygenation and/or heart pumping. But the flipside to that incredible technological breakthrough was that the medical community now needed to get more precise about the moment at which a person goes from being alive to being dead. After all, what had previously been a quick window between the two was now, due to life support technology, happening in extreme slow motion. In addition, organ transplanation was becoming more and more commonplace, meaning that it was no longer as simple as saying e.g. ‘I count someone as dead just in case their heart has stopped.'By the early 80s, the United States had settled on a standard definition for when someone counts as dead, which states that a person is dead if they have either permanently lost consciousness or permanently lost the ability to breathe and pump blood with their heart. That criterion makes certain life-saving practices possible; for example, it legally feasible for organ transplantation to begin once a patient has fallen into an irreversible coma, provided they agreed to donate their organs in advance.But should a person really count as dead just because they fell into an irreversible coma? We call that condition ‘brain death', or sometimes the wordier ‘death by neurological criteria', and we legally count it as a full death. Critics of the notion of brain death say that it should not count as death, because a person in this condition is still biologically alive. Their argument is that saying a person in this condition is dead is just a story we're telling ourselves.In this episode, Christos Lazaridis—who is a practicing neurointensivist—argues that even if that is a story we're telling ourselves, that's fine, because this is a corner case in which it makes sense for the social/legal status of being dead to come apart from the biological status of being dead. Tune in to hear why he thinks this is the case! Hosted on Acast. See acast.com/privacy for more information.

What if you could peer into the future of cardiac care and discover a method for Myocardial Bridge "unroofing" surgery that offers less pain, less scarring, and faster recovery? That future is now. Welcome to the new world of robotic cardiac surgery, as revealed by our guest, Director, Robotic and Minimally Invasive Cardiac Surgery at University of Chicago Medicine, Dr. Husam Balkhy. He shares his wealth of knowledge with us, unraveling his history and the potential of robotic surgery in treating heart conditions, specifically myocardial bridges. We discuss the intricate landscape of the heart, how different perspectives can help access deep coronary arteries or Myocardial Bridges and delve into the technicalities of unroofing myocardial bridges robotically. A process that requires precision, skill, favors experience and proper patient selection. Dr. Balkhy also shares the hurdles and rewards of robot-assisted surgery, emphasizing the pivotal role of a stabilizer in ensuring successful operations. This very stabilizer is currently being phased out and may not be replaced, rendering this procedure impossible and therefore no longer able to be performed going forward. Whether you're seeking to understand myocardial bridges, explore treatment options, or better understand a diagnosis, this episode will leave you with a deeper comprehension of robotic cardiac surgery's pioneering world and your options.  Cutting edge?  Not so much and happy to say. For more information about Dr. Balkhy, click  here To inquire about possible robotic surgery for your Myocardial Bridge call Ruth Buckner at Dr. Balkhy's office: 773-834-1612 To voice your concern about the deletion of the robotic stabilizer, you can contact Intuitive Surgical and watch for more information from me on the website, My Imperfect Heart

This episode recorded live at the 8th Annual Becker's HIT + DH + RCM Conference in Chicago features Karen Habercoss, Chief Privacy Officer at University of Chicago Medicine. Here, she discusses different use cases for AI, advice for leaders regarding innovation, and more.

In today's episode, Dr. Valluvan Jeevanandam, Deanna Bassette, Maureen Wilson, and Dr. Chase Corvin discuss the Bloodless Heart Surgery Program at the University of Chicago Medicine. We hear about the individualized, comprehensive cardiac surgical care they provide to Jehovah's Witnesses and other patients who cannot or choose not to receive blood products. The Bloodless Heart Surgery team also shares what they've learned about caring for Jehovah's Witnesses, combining respect for people's religious beliefs with surgical expertise.Dr. Valluvan Jeevanandam specializes in the surgical management of heart failure, and is an expert in high-risk cardiac surgery. He  has received national attention for his skill in performing bloodless cardiac surgery, which requires the use of precise surgical techniques to minimize blood loss during the procedure — sparing the need for a blood transfusion.Deanna Bassette is the Bloodless Advanced Practice Nurse Coordinator for the University of Chicago Medical Center. Deanna started as a registered nurse on the Cardiothoracic Surgical Floor in 2016 and transitioned to her role as Bloodless APN Coordinator in 2021. In this role, she serves a provider whose patient population consists of patients who are unable to take blood transfusions, even in life-or-death situations.Maureen Wilson has over 25 years in healthcare, starting off as a paramedic then nursing.  Her nursing experience includes working as an RN in multiple level one trauma centers as well as case management and currently as a Bloodless Coordinator at the university of Chicago hospital.Dr. Chase Corvin is the chief resident of General Surgery at the University of Chicago. Next year, he will begin his training in heart and lung surgery. In addition to his medical training, Dr. Corvin has degrees in economics and business administration. “Deep Cuts: Exploring Equity in Surgery” comes to you from the Department of Surgery at UChicago Medicine. Our host is Dr. Anthony Douglas. Our senior producer is Tony Liu. Our producers and editors include Alia Abiad, Caroline Montag, Nihar Rama, and Chuka Onuh. Our podcast cover art comes to you from Pombie Silverman, episode art from Sam Higgins, and music from Sen Morimoto off of Sooper Records. A special thanks this week to our guests, Dr. Valluvan Jeevanandam, Deanna Bassette, Maureen Wilson, and Dr. Chase Corvin. To send us questions or comments or find out more about our work, visit our website, https://deepcuts.surgery.uchicago.edu. You can also follow us on Instagram and X at @deepcutssurgery. To learn more about the Bloodless Heart Surgery Program at the University of Chicago Medicine, visit their website: https://www.uchicagomedicine.org/conditions-services/heart-vascular/heart-surgery/bloodless-heart-surgery

Research shows that screens – and the hyper-social connections they provide – can trigger dopamine responses in users so frequently it can turn us into actual addicts. And for kids, that's especially concerning. That's why some people are trying “anti-dopamine parenting.” Reset checks in with two experts on what a digital rest could look like for kids. Devorah Heitner is author of Screenwise: Helping Kids Thrive (and Survive) in Their Digital World and Growing Up in Public. Dr. Khalid Afzal is assistant professor of child and adolescent psychiatry at the University of Chicago Medicine.